October marks Menopause Awareness Month, a time to focus on the physical and emotional changes that affect more than 1 million American women each year. Fairhaven Health, a leader in women’s ...
New AlphaMedix data showed sustained and clinically meaningful responses across both RLT-naïve and RLT-exposed patients with unresectable or metastatic GEP-NETsFirst phase 2 study to evaluate TAT with ...
The 2025 ESMO annual meeting featured a metastatic castration-resistant prostate cancer (mCRPC) session and a presentation by ...
In September 2024, Sanofi entered an exclusive licensing agreement with Orano Med and RadioMedix to globally commercialize ...
Cullinan Therapeutics trades near cash after a major drop, with pipeline risks but upside from CLN-978 and Zipalertinib ...
Many medications can help lower high blood pressure (hypertension), but no single one works best for everyone. The good news is, with some patience and help from your healthcare provider, you’ll ...
In people with T2D, beta cells are reprogrammed into dysfunctional alpha-like cells, and the SMOC1 gene is the ... While current medications like GLP-1 receptor agonists, such as Ozempic, manage blood ...
If there's one thing that's crystal clear about Alzheimer's disease, it's this: It eats away at neurons and the links between them, ultimately destroying the neural networks that underlie our memories ...
University of Florence–led investigators report that estrogen-regulated renal progenitor cells shape pregnancy adaptation in mice with failure of estrogen receptor alpha signaling precipitating ...
The new Prescription Drug User Fee Act target date is now December 7, 2025. The Food and Drug Administration (FDA) has extended the review period for the supplemental New Drug Application (sNDA) for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback